logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-109. All clients entering inpatient treatment by primary drug and age at first use, 2011 or most recent year available

Part (v) All hypnotics and sedatives inpatient clients by country and age at first use

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium154633171985121550155
Bulgaria01000000134
Czech Republic2846313128533
Denmark05120000808
Germany63221212017131614617163
Estonia:::::::::::
Ireland171175821041849
Greece21062321026228
Spain:::::::::::
France1111122610043144
Italy:::::::::::
Cyprus00121100505
Latvia:::::::::::
Lithuania:::::::::::
Luxembourg1::::::::::
Hungary311105535547047
Malta:::::::::::
Netherlands420231485538289171
Austria31495030236036
Poland2112724::::::
Portugal:::::::::::
Romania03225142239104143
Slovenia:::::::::::
Slovakia1145696101263063
Finland812845100381048
Sweden11201442527161410153710371
United Kingdom3111517137404711081
Croatia:5423::::81:
Turkey2233310317219
Norway4112166113049453
Total20839720414612671609512663361521
 

Notes:

: Indicates no data are available.

(1) Data are from 2010.

(2) Data are from 2009. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(3) Data are from 1st of April 2010 to 31st March 2011.

(4) In Norway the criteria for selecting and grouping cases are main ICD-10 diagnosis codes F11-F16 and F18-F19.

The number of treatment clients in each country is listed in TDI-7

See also Table TDI-11 part(vii), part(viii)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2011- Table TDI Inpatient Treatment Centres

Page last updated: Friday, 26 April 2013